Injective drops around 11.5% after breaking below key short-term moving averages

Injective drops around 11.5% after breaking below key short-term moving averages
Injective slides 11.59% today

Injective (INJ) fell 11.59% following pronounced intraday selling pressure, even as recent ecosystem upgrades and institutional adoption continued to advance the platform. The scale of the decline is reinforced by the price slipping below both the 20-day and 50-day moving averages, which signals that sellers remain in control in the short to medium term.

INJ price prediction
24H -2.67%
$6.2
48H -11.15%
$5.66
7D -12.4%
$5.58
1M -8.95%
$5.8
3M -63.42%
$2.33
6M -76.92%
$1.47
12M 28.57%
$8.19
Current price: $6.37 -0.82 11.45%
Real-time Data 12:32
Daily range 6.33 Arrow from to Icon 7.13
Weekly range 6.56 Arrow from to Icon 8.25
Loading...

Highlights

  • Injective completed its Veyra mainnet upgrade with nearly unanimous staker approval, targeting expanded blockchain functionality.
  • Total tokenized real estate mortgages on Injective surpassed $1.5 billion, with a single day contribution of $524.8 million from PentivHQ.
  • INJ/USD trades below key short- and medium-term moving averages with bearish momentum, expected to range between $5.55 and $7.35 over the next five sessions.

Institutional pilots contrast with persistent downside as upgrade advances

Injective completed its Veyra mainnet upgrade after nearly unanimous approval from stakers, aiming to expand chain functionality. The blockchain surpassed $1.5 billion in tokenized real estate mortgages, with PentivHQ contributing $524.8 million in a single day. SEC filings confirmed the absence of a supply cap for INJ, and quarterly reports indicated $12.86 billion in trading volume and 90,000 daily wallets for Q3 2026. POSCO International and LG CNS initiated tokenization pilots using the Injective platform, accompanied by the launch of a new options primitive for six testnet markets, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, highlights the sharp 11.59% decline as a strong negative signal for INJ. He notes that slipping below both the 20-day and 50-day moving averages confirms the dominance of sellers. Institutional interest and technical upgrades have been insufficient to stem the downside, and weak indicators like the negative AO point to further risks. Kharitonov warns that volatility remains high and support at $5.9 is vulnerable. "I see little reason for confidence until INJ regains key levels, as further losses remain likely in the current climate."
Viktoras Karapetjanc, expert at Traders Union, sees the ongoing institutional adoption and platform upgrades as strong tailwinds for INJ. He believes the mainnet upgrade, large-scale tokenization, and enterprise pilots represent meaningful growth drivers. Despite short-term pressure, Karapetjanc points to the intact bullish structure above the 200-day average. "These fundamentals suggest further growth ahead — I expect the market to capitalize on new opportunities once selling subsides."
Jainam Mehta, market strategist, notes INJ is attempting to stabilize after heavy selling and a gap down. He observes a potential short-term range forming between $5.55 support and $7.35 resistance, with volatility likely to persist. Mehta suggests patience, watching for breakout attempts but remaining defensive if the $5.9 floor breaks. "If downside pressure fades, a tactical rebound toward resistance could offer contrarian entry for nimble traders."
Injective asset chart
Injective price dynamics. Source: TradingView.

Multi-horizon pressure persists as momentum weakens and volatility spikes

INJ/USD is trading below the 20-day and 50-day moving averages at $7.54 and $7.74, respectively, but remains above the 200-day average at $5.9. This configuration points to ongoing short- and medium-term pressure from sellers, while the longer-term trend is still underpinned by a bullish alignment between the 50-day and 200-day moving averages. Immediate focus is on support at $5.9 and resistance at $6.54. Among momentum indicators, the MACD shows bearish momentum and the ADX signals a weak trend. The RSI, Stochastic RSI, and CCI are all neutral, and the Bull/Bear Power (BBP) is barely positive, suggesting a near balance between buyers and sellers. The Awesome Oscillator (AO) is negative, adding to the downside signals. INJ/USD has dropped to $6.51, losing $0.85 or 11.59% today after a $0.26 (3.53%) downside gap. Volatility over the session is elevated at 9.02%.

Earlier, analysts noted that Injective was trading under sustained selling pressure despite positive ecosystem developments and robust protocol usage. This update adds that elevated volatility and technical weakness currently favor a lower trading band, making the $5.9 support level critical to monitor for any potential shift in trend.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.